TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
ARTV

Artiva Biotherapeutics, Inc.

Healthcare · Biotechnology

7.70$ -4.6% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ARTV
Line item 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
40.5% 89.3% 95.5% 78.7% 75.9% 90.0% 86.0%
38.7% 87.0% 94.7% 77.1% 50.9% 19.2% 20.4%
38.7% 87.0% 94.7% 77.1% 73.2% 88.5% 82.5%
– 0.0% 0.3% 0.4% 1.7% 0.1% 0.6%
181.8% 173.8% 152.3% 205.7% 254.1% 10.9% 16.0%
19.5% 19.7% 11.4% 19.3% 11.6% 5.8% 10.0%
4.3% 1.6% 0.3% 2.6% 3.4% 1.8% 2.3%
5.3% 7.4% 0.8% 0.8% 0.6% 0.5% 0.3%
116.6% – – – – – –
-81.8% -73.8% -52.3% -105.7% -154.1% 89.1% 84.0%
-82.4% -75.2% -55.2% -114.7% -172.5% -117.7% -252.4%
– 60.1% 10.3% 13.2% 22.1% 11.6% 18.7%

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?